John Perrett
Impact in
-
- Neonatal Respiratory Health Research
- Cystic Fibrosis Research Advances
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory Support and Mechanisms
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
- Respiratory Support and Mechanisms 3
- Neonatal Respiratory Health Research 3
- Cystic Fibrosis Research Advances 2
- Respiratory and Cough-Related Research 2
- Pleural and Pulmonary Diseases 1
- Co-authors
- Kulasiri A. Gunawardena (6 shared papers)Neil Entwistle (3 shared papers)Kristina Forsman‐Semb (3 shared papers)Noel Snell (1 shared paper)Robert A. Stockley (1 shared paper)Anthony De Soyza (1 shared paper)Christopher D. O’Brien (2 shared papers)Claus Vogelmeier (2 shared papers)
- Journals
- Respiratory Medicine (2 papers)COPD Journal of Chronic Obstructive Pulmonary Disease (2 papers)British Journal of Clinical Pharmacology (1 paper)European Respiratory Journal (1 paper)Blood (1 paper)
- Partner nations
- United KingdomSwedenGermany
In The Last Decade
John Perrett
10 papers receiving 412 citations
Peers
Comparison fields: 5 of 61
- Pulmonary and Respiratory Medicine 223
- Pharmacology 52
- Immunology 123
- Cancer Research 56
- Physiology 71
Countries citing papers authored by John Perrett
This map shows the geographic impact of John Perrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Perrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Perrett more than expected).
Fields of papers citing papers by John Perrett
This network shows the impact of papers produced by John Perrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Perrett. The network helps show where John Perrett may publish in the future.
Co-authors
The 22 scholars most cited alongside John Perrett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 148 | |
| 2 | 2012 | 76 | |
| 3 | 2012 | 68 | |
| 4 | 2003 | 58 | |
| 5 | 2003 | 21 | |
| 6 | The role of the novel D2/beta2-agonist, Viozan (sibenadet HCl), in the treatment of symptoms of chronic obstructive pulmonary disease: results of a large-scale clinical investigation. | 2003 | 20 |
| 7 | 2013 | 15 | |
| 8 | The P-2t antagonist AR-C69931MX is a more effective inhibitor of ADP-induced platelet aggregation than clopidogrel. | 1999 | 12 |
| 9 | 2011 | 4 | |
| 10 | 2012 | 2 |
About John Perrett
John Perrett is a scholar working on Pulmonary and Respiratory Medicine, Pharmacology, Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology, having authored 10 papers that have together received 424 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Respiratory Support and Mechanisms (3 papers), Neonatal Respiratory Health Research (3 papers), Cystic Fibrosis Research Advances (2 papers), Respiratory and Cough-Related Research (2 papers), Pharmacological Effects and Toxicity Studies (1 paper), Pleural and Pulmonary Diseases (1 paper) and Blood disorders and treatments (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (223 citations), Pharmacology (52 citations), Immunology (123 citations), Cancer Research (56 citations) and Physiology (71 citations). John Perrett has collaborated with scholars based in United Kingdom, Sweden and Germany. Frequent co-authors include Kulasiri A. Gunawardena, Neil Entwistle, Kristina Forsman‐Semb, Noel Snell, Robert A. Stockley, Anthony De Soyza, Christopher D. O’Brien, Claus Vogelmeier, J.S. Elborn and Joanna Marks-Kończalik. Their work appears in journals such as Respiratory Medicine, COPD Journal of Chronic Obstructive Pulmonary Disease, British Journal of Clinical Pharmacology, European Respiratory Journal and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.